Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Capsaicin for Non-allergic Rhinitis
NCT05093478Phase 3Completed
- Sponsor
- UTHealth Houston
- Start
- Sep 2019
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of capsaicin in non-allergic rhinitis (NAR), sponsored by UTHealth Houston. Primary endpoints: Runny Nose as Measured by the Visual Analog Scale at 12 weeks and Nasal Symptoms of Congestion as Measured by the Visual Analog Scale at 12 weeks. Started Sep 2019; status: completed.
02
Drugs
capsaicin
03
Conditions
non-allergic rhinitis (NAR)
Beyond the preview
Go deeper on NCT05093478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05093478.